Lenka Dubska-Zdrazilova

Brno, JM, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Emergence and genomic characterization of hypervirulent ST23/K1 Klebsiella pneumoniae: local epidemiology and global context.

Emergence and genomic characterization of hypervirulent ST23/K1 Klebsiella pneumoniae: local epidemiology and global context.

Journal: Frontiers in microbiology

Published: December 01, 2025

Description of TEMPI syndrome in Waldenström's macroglobulinemia.

Description of TEMPI syndrome in Waldenström's macroglobulinemia.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: September 17, 2025

Successful treatment of relapsed Waldenström's macroglobulinemia with proteasome inhibitors (bortezomib and subsequently ixazomib) in combination with rituximab and dexamethasone. A case report and review of the of proteasome inhibitors in Waldenström's….

Successful treatment of relapsed Waldenström's macroglobulinemia with proteasome inhibitors (bortezomib and subsequently ixazomib) in combination with rituximab and dexamethasone. A case report and review of the of proteasome inhibitors in Waldenström's….

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: January 08, 2025

Current real-world evidence on characteristics and treatment patterns of lung cancer in the single cancer center in the Czech Republic - data from Masaryk Memorial Cancer Institute registry in 2018- 2022.

Current real-world evidence on characteristics and treatment patterns of lung cancer in the single cancer center in the Czech Republic - data from Masaryk Memorial Cancer Institute registry in 2018- 2022.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: January 08, 2025

Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trial.

Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trial.

Journal: Therapeutic advances in medical oncology

Published: September 10, 2024

Early changes of peripheral circulating immune subsets induced by PD-1 inhibitors in patients with advanced malignant melanoma and non-small cell lung cancer.

Early changes of peripheral circulating immune subsets induced by PD-1 inhibitors in patients with advanced malignant melanoma and non-small cell lung cancer.

Journal: BMC cancer

Published: July 17, 2024

Monoclonal gammopathy of clinical signifi cance with osteosclerotic lesions - a case report and a literature review.

Monoclonal gammopathy of clinical signifi cance with osteosclerotic lesions - a case report and a literature review.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: July 03, 2024

Molecular portraits of colorectal cancer morphological regions.

Molecular portraits of colorectal cancer morphological regions.

Journal: eLife

Published: November 13, 2023

Emergency medicine pharmacotherapy compromises accuracy of plasma creatinine determination by enzyme-based methods: real-world clinical evidence and implications for clinical practice.

Emergency medicine pharmacotherapy compromises accuracy of plasma creatinine determination by enzyme-based methods: real-world clinical evidence and implications for clinical practice.

Journal: Frontiers in medicine

Published: June 19, 2023

Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing.

Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing.

Journal: JCO precision oncology

Published: June 14, 2022

Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial.

Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 06, 2021

PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study.

PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study.

Journal: Therapeutic advances in medical oncology

Published: September 05, 2021

Showing 1-12 of 55

Last Updated: 09/26/2026